Metropolitan Life Insurance Company (MetLife)’s RenaissanceRe RNR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-9,162
Closed -$1.55M 2605
2021
Q4
$1.55M Sell
9,162
-400
-4% -$62.7K 0.02% 676
2021
Q3
$1.33M Sell
9,562
-861
-8% -$130K 0.02% 770
2021
Q2
$1.55M Sell
10,423
-62
-0.6% -$9.86K 0.02% 689
2021
Q1
$1.68M Buy
10,485
+412
+4% +$66.5K 0.03% 608
2020
Q4
$1.67M Sell
10,073
-326
-3% -$55.4K 0.03% 568
2020
Q3
$1.77M Sell
10,399
-303
-3% -$53.6K 0.03% 465
2020
Q2
$1.83M Sell
10,702
-1,809
-14% -$297K 0.03% 437
2020
Q1
$1.87M Sell
12,511
-675
-5% -$120K 0.04% 412
2019
Q4
$2.58M Buy
13,186
+50
+0.4% +$9.47K 0.04% 411
2019
Q3
$2.54M Buy
13,136
+445
+4% +$82.8K 0.04% 386
2019
Q2
$2.26M Buy
12,691
+508
+4% +$83.5K 0.04% 466
2019
Q1
$1.75M Buy
12,183
+487
+4% +$68.1K 0.03% 556
2018
Q4
$1.56M Buy
11,696
+35
+0.3% +$4.57K 0.03% 559
2018
Q3
$1.56M Sell
11,661
-112
-1% -$14.5K 0.03% 665
2018
Q2
$1.42M Buy
11,773
+109
+0.9% +$14.1K 0.02% 737
2018
Q1
$1.62M Buy
11,664
+65
+0.6% +$8.44K 0.02% 666
2017
Q4
$1.46M Sell
11,599
-26,423
-69% -$3.55M 0.02% 717
2017
Q3
$5.14M Sell
38,022
-324
-0.8% -$45.6K 0.03% 571
2017
Q2
$5.33M Buy
38,346
+148
+0.4% +$20.8K 0.04% 531
2017
Q1
$5.53M Sell
38,198
-290
-0.8% -$41.5K 0.04% 528
2016
Q4
$5.24M Sell
38,488
-195
-0.5% -$25K 0.04% 540
2016
Q3
$4.65M Sell
38,683
-1,775
-4% -$209K 0.03% 577
2016
Q2
$4.75M Buy
+40,458
New +$4.64M 0.04% 547
2014
Q3
Sell
-33,951
Closed -$3.6M 2715
2014
Q2
$3.6M Sell
33,951
-844
-2% -$86.5K 0.03% 708
2014
Q1
$3.37M Buy
34,795
+33,510
+2,608% +$3.14M 0.02% 735
2013
Q4
$125K Hold
1,285
﹤0.01% 2641
2013
Q3
$116K Buy
1,285
+45
+4% +$3.93K ﹤0.01% 2660
2013
Q2
$108K Buy
+1,240
New +$110K ﹤0.01% 2645

Other funds holding RNR

Metropolitan Life Insurance Company (MetLife)'s RNR Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of RenaissanceRe (RNR) in Q1 2022, closing a stake of 9,162 shares — an estimated $1.55M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in RNR in Q2 2013 and held it in 28 quarters. The position peaked at $5.53M in Q1 2017. 320 funds tracked by Wall St. Rank hold RNR as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining RenaissanceRe position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 9,162 RenaissanceRe shares in Q1 2022, an estimated $1.55M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in RenaissanceRe in Q2 2013 and held it in 28 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s RenaissanceRe position peaked at $5.53M in Q1 2017.
  • 320 funds tracked by Wall St. Rank held RenaissanceRe as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.